imugene finishes phase 1a monotherapy dose escalation of pd1-vaxx and bolsters management team
Published 2 years ago • 1.3K plays • Length 6:29Download video MP4
Download video MP3
Similar videos
-
4:00
imugene doses first patient in pd1-vaxx combination trial
-
4:27
imugene pd1 vaxx 1080p
-
32:59
imugene's science series: pd1-vaxx | b cell immunotherapy
-
4:15
imugene to commence new phase 2 pd1-vaxx bowel cancer trial
-
6:12
imugene @ aacr 2020: pd1-vaxx (imu-201) phase 1 briefing
-
5:18
im-21 - fill up oil -
-
4:15
how to expand effective microorganism (em)
-
26:16
a californian cancer killer professor yuman fong and his work with imugene
-
5:45
imugene begins dosing in cohort three of vaxinia monotherapy dose escalation trial
-
6:12
imugene talks dose escalation for checkvacc's city of hope trial
-
0:37
imugene's science series: pd1-vaxx (intro)
-
5:20
imugene welcomes dosing of first patient in nextherizon phase 2 clinical trial
-
5:15
imugene thrilled as first patients dosed in vaxinia mast combination study
-
6:15
imugene ceo hails clinical milestone for her-vaxx cancer immunotherapy
-
5:00
imugene doses first patient in intravenous monotherapy arm of phase 1 clinical trial
-
5:33
imugene ceo says fda ind approval for pd1-vaxx is 'huge news' for the company
-
5:39
imugene announces clinical trial supply agreement with merck kgaa and pfizer for her-vaxx
-
4:28
imugene with proactive at asx small and mid cap conference
-
4:50
imugene talks abl partnership for vaxinia and $80 million institutional capital raise
-
4:45
imugene delighted as first cohort 3 patient dosed in checkvacc trial